Presentation Information
[S17-1]Drug discovery and development targeting SARS-CoV-2 main protease
○Nobuyo Higashi-Kuwata1, Shin-ichiro Hattori1, Naoki Kishimoto2, Nobutoki Takamune2, Hiromi Ogata-Aoki1,3, Haydar Bulut4, Shogo Misumi2, Hirokazu Tamamura5, Hiroaki Mitsuya1,4,6 (1. Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, 2. Graduate School of Pharmaceutical Sciences, Kumamoto University, 3. Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 4. Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, 5. Lab. Biomat. Bioeng., Inst. Sci. Tokyo, 6. Kumamoto University Hospital)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.